Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Biomarkers

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Biomarkers.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
10.127
Biomarkers
  1. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017 Oct 01; 32(10):1750-1757.
    View in: PubMed
    Score: 0.522
  2. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort. Nephrol Dial Transplant. 2017 02 01; 32(2):370-377.
    View in: PubMed
    Score: 0.499
  3. Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients. J Ren Nutr. 2017 01; 27(1):26-36.
    View in: PubMed
    Score: 0.483
  4. Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients. Semin Dial. 2014 Jul-Aug; 27(4):415-23.
    View in: PubMed
    Score: 0.397
  5. Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant. 2013 Oct; 28(10):2535-45.
    View in: PubMed
    Score: 0.391
  6. Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant. 2013 Aug; 28(8):2146-55.
    View in: PubMed
    Score: 0.387
  7. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
    View in: PubMed
    Score: 0.378
  8. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013 Jul; 28(7):1936-45.
    View in: PubMed
    Score: 0.370
  9. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant. 2010 Sep; 25(9):3003-11.
    View in: PubMed
    Score: 0.310
  10. Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology (Carlton). 2009 Jun; 14(4):408-15.
    View in: PubMed
    Score: 0.293
  11. Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol. 2007 Sep; 2(5):872-5.
    View in: PubMed
    Score: 0.259
  12. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007 May; 30(5):1049-55.
    View in: PubMed
    Score: 0.251
  13. Change Over Time in Pre-End-Stage Renal Disease 24-Hour Urine Creatinine as Muscle Mass Surrogate and Post-End-Stage Renal Disease Mortality. J Ren Nutr. 2024 Nov; 34(6):500-508.
    View in: PubMed
    Score: 0.204
  14. Novel monitoring of renal function and medication levels in saliva and capillary blood of patients with kidney disease. Curr Opin Nephrol Hypertens. 2022 01 01; 31(1):100-108.
    View in: PubMed
    Score: 0.175
  15. Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in Mortality. J Ren Nutr. 2023 Jan; 33(1):69-77.
    View in: PubMed
    Score: 0.175
  16. Association of lactate dehydrogenase with mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2021 03 29; 36(4):704-712.
    View in: PubMed
    Score: 0.166
  17. Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. Atherosclerosis. 2019 11; 290:59-65.
    View in: PubMed
    Score: 0.150
  18. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115.
    View in: PubMed
    Score: 0.140
  19. Eating During Hemodialysis Treatment: A?Consensus Statement From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018 01; 28(1):4-12.
    View in: PubMed
    Score: 0.133
  20. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients. Am J Nephrol. 2017; 46(5):408-416.
    View in: PubMed
    Score: 0.132
  21. Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2017; 46(2):120-130.
    View in: PubMed
    Score: 0.129
  22. Serum sodium and mortality in a national peritoneal dialysis cohort. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1224-1233.
    View in: PubMed
    Score: 0.128
  23. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1109-1117.
    View in: PubMed
    Score: 0.127
  24. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
    View in: PubMed
    Score: 0.127
  25. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016 08; 90(2):262-271.
    View in: PubMed
    Score: 0.119
  26. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96.
    View in: PubMed
    Score: 0.117
  27. Candidate Surrogate End Points for ESRD after AKI. J Am Soc Nephrol. 2016 09; 27(9):2851-9.
    View in: PubMed
    Score: 0.117
  28. Hypomagnesemia and Mortality in Incident Hemodialysis?Patients. Am J Kidney Dis. 2015 Dec; 66(6):1047-55.
    View in: PubMed
    Score: 0.112
  29. Critical appraisal of biomarkers of dietary intake and nutritional status in patients undergoing dialysis. Semin Dial. 2014 Nov-Dec; 27(6):586-9.
    View in: PubMed
    Score: 0.104
  30. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014 Aug; 29(8):1554-62.
    View in: PubMed
    Score: 0.102
  31. Interpreting tests of iron sufficiency in patients with ESRD: inflammation, evidence, and recommendations. Nephrol News Issues. 2014 Feb; 28(2):6-9.
    View in: PubMed
    Score: 0.101
  32. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48.
    View in: PubMed
    Score: 0.101
  33. Ecstacy-associated hyponatremia: why are women at risk? Nephrol Dial Transplant. 2013 Sep; 28(9):2206-9.
    View in: PubMed
    Score: 0.097
  34. Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J Nutr. 2013 Jul; 143(7):1084-92.
    View in: PubMed
    Score: 0.097
  35. Role of HDL dysfunction in end-stage renal disease: a double-edged sword. J Ren Nutr. 2013 May; 23(3):203-6.
    View in: PubMed
    Score: 0.096
  36. Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. Mayo Clin Proc. 2013 May; 88(5):479-86.
    View in: PubMed
    Score: 0.096
  37. Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes. Clin J Am Soc Nephrol. 2012 Nov; 7(11):1859-71.
    View in: PubMed
    Score: 0.092
  38. Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens. 2012 Jul; 21(4):389-403.
    View in: PubMed
    Score: 0.091
  39. Correlates of low hemoglobin A1c in maintenance hemodialysis patients. Int Urol Nephrol. 2013 Aug; 45(4):1079-90.
    View in: PubMed
    Score: 0.090
  40. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol. 2012 Apr 15; 175(8):793-803.
    View in: PubMed
    Score: 0.089
  41. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012 Feb 07; 125(5):677-84.
    View in: PubMed
    Score: 0.088
  42. Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2712-21.
    View in: PubMed
    Score: 0.086
  43. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1973-81.
    View in: PubMed
    Score: 0.085
  44. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol. 2011 Jun; 6(6):1463-73.
    View in: PubMed
    Score: 0.083
  45. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011 Jan; 21(1):100-4.
    View in: PubMed
    Score: 0.082
  46. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010 Mar-Apr; 23(2):148-56.
    View in: PubMed
    Score: 0.078
  47. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 2010 Jul; 20(4):243-54.
    View in: PubMed
    Score: 0.077
  48. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010 Apr; 5(4):683-92.
    View in: PubMed
    Score: 0.077
  49. Iron therapy in chronic kidney disease: current controversies. J Ren Care. 2009 Dec; 35 Suppl 2:14-24.
    View in: PubMed
    Score: 0.076
  50. Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis. 2009 Dec; 54(6):1062-71.
    View in: PubMed
    Score: 0.074
  51. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr. 2009 Aug; 90(2):407-14.
    View in: PubMed
    Score: 0.074
  52. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol. 2009 Feb; 4(2):435-41.
    View in: PubMed
    Score: 0.071
  53. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr. 2008 Dec; 88(6):1485-94.
    View in: PubMed
    Score: 0.071
  54. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1691-701.
    View in: PubMed
    Score: 0.070
  55. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1769-76.
    View in: PubMed
    Score: 0.069
  56. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008 Nov; 19(11):2193-203.
    View in: PubMed
    Score: 0.069
  57. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int. 2007 Nov; 72(9):1149-56.
    View in: PubMed
    Score: 0.065
  58. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol. 2006 Sep; 1 Suppl 1:S9-18.
    View in: PubMed
    Score: 0.061
  59. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2006 Jul; 48(1):59-68.
    View in: PubMed
    Score: 0.060
  60. The latest addition to the inflammatory homeboys in chronic kidney disease: interleukin-8. Nephron Clin Pract. 2006; 102(2):c59-60.
    View in: PubMed
    Score: 0.058
  61. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005 Sep; 46(3):489-500.
    View in: PubMed
    Score: 0.057
  62. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005 Sep; 20(9):1880-8.
    View in: PubMed
    Score: 0.056
  63. A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrol. 2005 Jan; 63(1):22-34.
    View in: PubMed
    Score: 0.054
  64. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004 Jan; 19(1):141-9.
    View in: PubMed
    Score: 0.050
  65. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003 Oct; 42(4):761-73.
    View in: PubMed
    Score: 0.049
  66. Association of serum globulin with all-cause mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2022 09 22; 37(10):1993-2003.
    View in: PubMed
    Score: 0.046
  67. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001 Mar; 37(3):564-72.
    View in: PubMed
    Score: 0.041
  68. Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients. J Clin Endocrinol Metab. 2019 10 01; 104(10):4848-4856.
    View in: PubMed
    Score: 0.038
  69. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis. J Ren Nutr. 2019 07; 29(4):310-321.
    View in: PubMed
    Score: 0.036
  70. Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology. Cardiorenal Med. 2019; 9(2):69-82.
    View in: PubMed
    Score: 0.035
  71. Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.034
  72. Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017 Aug 07; 12(8):1274-1283.
    View in: PubMed
    Score: 0.032
  73. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. J Am Soc Nephrol. 2015 Jul; 26(7):1671-81.
    View in: PubMed
    Score: 0.027
  74. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Hemodial Int. 2014 Oct; 18(4):720-4.
    View in: PubMed
    Score: 0.027
  75. Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich). 2014 Nov; 16(11):805-13.
    View in: PubMed
    Score: 0.026
  76. Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013 Mar; 8(3):460-7.
    View in: PubMed
    Score: 0.023
  77. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol. 2012 Aug; 7(8):1272-84.
    View in: PubMed
    Score: 0.023
  78. Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol. 2010 Jul; 74(1):12-8.
    View in: PubMed
    Score: 0.020
  79. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010 Jul; 85(7):609-17.
    View in: PubMed
    Score: 0.020
  80. Homocysteine in uraemia--a puzzling and conflicting story. Nephrol Dial Transplant. 2005 Jan; 20(1):16-21.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.